ProKidney Corp (NASDAQ:PROK): Buy, Sell Or Hold At $2.20?
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level
In last trading session, RAPT Therapeutics Inc (NASDAQ:RAPT) saw 0.42 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price
In last trading session, Cellectar Biosciences Inc (NASDAQ:CLRB) saw 0.51 million shares changing hands with its beta currently measuring 1.01. Company’s recent per share price
In last trading session, Avadel Pharmaceuticals plc (NASDAQ:AVDL) saw 0.87 million shares changing hands with its beta currently measuring 1.80. Company’s recent per share price
In last trading session, ESS Tech Inc (NYSE:GWH) saw 0.62 million shares changing hands with its beta currently measuring 1.50. Company’s recent per share price
In last trading session, AC Immune SA (NASDAQ:ACIU) saw 0.39 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price
In last trading session, Onconetix Inc (NASDAQ:ONCO) saw 0.54 million shares changing hands with its beta currently measuring 3.35. Company’s recent per share price level
In last trading session, Enliven Therapeutics Inc (NASDAQ:ELVN) saw 0.48 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price
In last trading session, Turnstone Biologics Corp (NASDAQ:TSBX) saw 0.36 million shares changing hands with its beta currently measuring 0. Company’s recent per share price
In last trading session, LivaNova PLC (NASDAQ:LIVN) saw 0.89 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level
© 2024, Powered by Smart TechOne